Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Fluidigm

Fluidigm?uq=UG6efJS6
1999 FOUNDED
PUBLIC STATUS
501-600 EMPLOYEES
FLDM STOCK SYMBOL
2 INVESTMENTS
$7.51 SHARE PRICE (As of Friday Closing)
Description

Designer, manufacturer and distributor of biological research equipment based on integrated fluidic circuit technology. The company's biological research equipment leverage the capabilities of multilayer soft lithography to create microfluidic devices, enabling companies in protein crystallization, genetic analysis as well as help them in exploration and analysis of individual cells.

Formerly Known As
Mycometrix
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Other Commercial Products
Other Industries
Other Semiconductors
Biotechnology
Stock Exchange
NAS
Primary Office
  • 7000 Shoreline Court
  • Suite 100
  • San Francisco, CA 94080
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Fluidigm’s full profile, request a free trial.

Fluidigm Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.46 - $8.35 $311M $7.95 -$1.45 180K 39.2M

Fluidigm Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 348,843 360,427 335,614 410,360
Revenue 104,167 101,937 104,446 114,712
EBITDA (28,678) (39,366) (56,419) (32,867)
Net Income (55,889) (60,535) (75,985) (53,315)
Total Assets 259,103 287,351 306,395 370,050
Total Debt 166,758 195,238 194,951 194,673
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Fluidigm Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Fluidigm‘s full profile, request access.

Request full access to PitchBook

Fluidigm Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Fluidigm‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Fluidigm Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000 00000000 13-Feb-2014 000000000000000000 00000 Medical Supplies
Helicos Biosciences (Patent portfolio) 28-Jun-2013 Corporate Asset Purchase 00.00 Buildings and Property
To view this company’s complete investment and acquisition history, request access »

Fluidigm Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Fluidigm‘s full profile, request access.

Request full access to PitchBook

Fluidigm Executive Team (8)

Name Title Board
Seat
Contact
Info
Christopher Linthwaite Chief Executive Officer, President, Director & Chief Operating Officer
Vikram Jog Chief Financial Officer & Principal Accounting Officer
Fredric Walder Chief Operating Officer
Steven McPhail Chief Commercial Officer
Peter Karlberg Ph.D Senior Director - Applied Markets EMEA

1 Former Executive

You’re viewing 5 of 8 executives. Get the full list »

Fluidigm Board Members (8)

Name Representing Role Since Contact
Info
Nicolas Barthelemy Self Board Member 000 0000
Samuel Colella Self Chairman & Director 000 0000

6 Former Board Members

You’re viewing 2 of 8 board members. Get the full list »